You Position: Home > Journal issue

Chinese Journal of Pharmaceuticals

Items 1-5 of 17
«Preious | of 4 |
1

Discussion on the Main Risk Points of Supplier Management in Pharmaceutical GMP

Chinese Journal of Pharmaceuticals, Volume 52, Issue 1,2021, Pages 131-136, doi:10.16522/j.cnki.cjph.2021.01.015

2

Discussion on the System of Drug Patent Term Compensation

Chinese Journal of Pharmaceuticals, Volume 52, Issue 1,2021, Pages 143-146, doi:10.16522/j.cnki.cjph.2021.01.017

3

信息动态

Chinese Journal of Pharmaceuticals, Volume 52, Issue 1,2021, Pages 147-150,

4

Overviews of the New Drug in 2020 Approved by U.S.FDA

Chinese Journal of Pharmaceuticals, Volume 52, Issue 1,2021, Pages 1-31, doi:10.16522/j.cnki.cjph.2021.01.001

5

Improved Synthetic Process of Exemestane

Chinese Journal of Pharmaceuticals, Volume 52, Issue 1,2021, Pages 56-58, doi:10.16522/j.cnki.cjph.2021.01.004

Items 1-5 of 17
«Preious | of 4 |
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn